Sartorius

Sartorius is a global biopharmaceutical research and development leader founded in 1870. The company specializes in advanced biopharmaceutical products, including vaccination research, regenerative medicine, and cellular biology. Operating with over 10,000 employees, Sartorius maintains a robust international presence across 31 locations. Their technical portfolio encompasses laboratory equipment, pharmaceutical production technology, and analytical instrumentation designed for scalable drug discovery and commercial production.

The firm provides critical infrastructure for the biopharma industry, focusing on single-use technologies, chromatography, and filtration systems. These solutions support the entire lifecycle of drug development, from initial research to large-scale manufacturing. Sartorius integrates engineering, validation, and service training to ensure high-performance outcomes for global clients. Meet Sartorius's team to understand the organizational structure and the expertise driving their innovation in life science research and biotechnology.

With a fiscal year ending on December 31, Sartorius continues to expand its market influence through strategic investments in next-generation analytical technology. The company’s commitment to high-quality engineering and technical support positions it as a key partner in the global pharmaceutical sector. By leveraging advanced hardware and software solutions, Sartorius facilitates complex clinical processes and supports the evolving needs of the medical and health industries. Their long-standing history and commitment to scientific advancement underscore their role as a cornerstone of modern biopharmaceutical manufacturing and research, generating annual revenue of $3.5B.